---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-018675"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2026-01-22T23:59:59+00:00"
generated_at: "2026-05-16T08:40:36.303238+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Plus Therapeutics updates corporate presentation; no specific new data disclosed

## Summary
- Filed updated investor presentation under Item 8.01.
- Presentation slides filed as Exhibit 99.1, but no material changes evident from filing text.
- No financial results, guidance, or operational milestones mentioned.

## SEC filing metadata
- accession: 0001193125-26-018675
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2026-01-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312526018675/0001193125-26-018675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312526018675/d90055d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-018675
- JSON: https://secwatch.observer/filing/0001193125-26-018675.json
- Plain text: https://secwatch.observer/filing/0001193125-26-018675.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.